Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Patient Monitors

Oct. 5, 2026 — Abbott has announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF ...

Home October 05, 2026
Home
News | Cardiovascular Business

Oct. 5, 2026 – Endologix Holdings, LLC has announced Rhevera Medical as its new corporate brand. The new identity ...

Home October 05, 2026
Home
News | Pediatric Cardiology

Oct. 1, 2026 — Edwards Lifesciences has received U.S. Food and Drug Administration (FDA) approval for its AUTUS Size ...

Home October 02, 2026
Home
News | Remote Monitoring

Sept. 29, 2026 — Vivalink has published new results from a new survey examining patient attitudes toward home-based ...

Home October 01, 2026
Home
News | Heart Valve Technology

Sept. 22, 2026 — Following transcatheter aortic valve implantation (TAVI), disturbances in the heart’s electrical ...

Home September 25, 2026
Home
News | Heart Valve Technology

Sept. 22, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai have received a $3.6 million, four-year ...

Home September 24, 2026
Home
News | FDA

Sept. 22, 2026 — Merck recently announced the U.S. Food and Drug Administration (FDA) has approved an update to the U.S ...

Home September 23, 2026
Home
Are Ambulatory Surgical Centers the Future of Cardiology?
Feature | Heart Failure | Kyle Hardner

The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a ...

Home September 11, 2026
Home
News | Heart Failure

Sept. 9, 2026— Atman Health has been selected by the Advanced Research Projects Agency for Health (ARPA-H) to develop an ...

Home September 11, 2026
Home
News | Cardiovascular Clinical Studies

Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...

Home September 02, 2026
Home
News | Heart Failure

Aug. 31, 2026 — A new heart failure (HF) treatment effect calculator could help overcome one of the largest barriers to ...

Home August 31, 2026
Home
News | ESC

Aug. 28, 2026 — At ESC Congress in Munich, the European Society of Cardiology released its first updated heart failure ...

Home August 28, 2026
Home
News | Innovative Hospitals

Aug. 27, 2026 — NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator ...

Home August 27, 2026
Home
News | FDA

Aug. 24, 2026 — Tempus AI, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Home August 24, 2026
Home
Subscribe Now